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Erythrocytes infected with mature Plasmodiumfalciparum parasites sequester within
the capillaries and postcapillary venules of organs such as the heart, placenta, and
brain, thereby avoiding circulation through the spleen and subsequent destruction
by host immune defences (1, 2) . The sequestration of infected erythrocytes in the
cerebral circulation, however, may result in thedeath ofthehost from cerebral malaria.
It has previously been determined from autopsy studies that cytoadherence occurs
at least in part at thickened areasof the erythrocytemembrane called "knobs" (3-5).
A major structural protein in knobs is the knob-associated histidine-rich protein
(KAHRP)t (6-8). Studies of cytoadherence in vitro using umbilical vein endo-
thelium or amelanotic melanoma cells also showed a correlation between binding
andthepresence ofknobs (9-11) . Culture-adapted isolates ofP . falciparum often lose
the ability to cytoadhere in vitro . This occurs independently of whether the knob
positive (K +) phenotype is retained or lost (K-), and therefore knobs were previ-
ously considered necessary but not sufficient for cytoadherence in vitro (12) .
A major host cell receptor for cytoadherence to C32 melanoma cells is the Mr
88-kD leukocyte differentiation antigen, CD36, which is defined by the mAbsOKM5
andCI Mega I (13-17) . This antigen is expressed in variable amounts on the surface
of umbilical vein endothelium, C32 melanoma cells, monocytes, and platelets, and
may serve as a receptor for the platelet protein, thrombospondin (TSP) (18) . Im-
mobilized, calcium-replete TSP is also able to bind infected erythrocytes, although
somemelanoma cells that express this protein do not bind infected erythrocytes (19,
20) . Some short- and long-term cultured isolates ofP . falciparum bind to both CD36
and TSP (15, 19), and, recently, another endothelial cell surface molecule, the inter-
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cellular adhesion molecule 1 (ICAM 1), has been shownto be involved in cytoadher-
ence in vitro (21).
Although knob-independent cytoadherence has been documented for immature
gametocytes of P. falcißarum (22) and other malaria species, such as P. knowlesi (23),
P . berghei (24), and P . chabaudi (25), it has only recently been described for the asexual
stages of P. faleiparum (26, 27). In both cases described, K- cytoadherent clones were
obtained by repeated selection for a minor population of K--infected erythrocytes
that bound to melanoma cells. Knob-independent cytoadherence may occur via a
similar mechanism to that of K' lines, as Udomsangpetch et al. (27) showed that
cytoadherence of their K- line was inhibited by mAb OKM5 .
We have investigated the cytoadherence of a K- clone (B8C+) of P. falciparum to
establish the characteristics of knob-independent cytoadherence. The cytoadherence
of B8C+ to host cell proteins CD36, TSP, and ICAM 1, and the trypsin sensitivity,
surface labeling, and immunoprecipitation of the parasite molecules involved in this
process have been examined .
Materials and Methods
Selection ofa K- Cytoadherent Clone(B8C').
￿
The cytoadherence of an initially noncytoad-
herent, knobless ItG2F6 clone, B8, was enhanced by repeatedly selecting and culturing those
few infected erythrocytes that bound to C32 melanoma cells (American Type Culture Collec-
tion, Rockville, MD) (26). Briefly, cytoadherence assays were performed as previously de-
scribed (10, 28), except that, after washing away all unbound cells, complete medium with
10% AB human serum and uninfected erythrocytes at 2% hematocritwere added. Cultures
were transferred to freshdishes afterschizont rupture when erythrocytes infected with ring-
stage parasites were no longer cytoadherent. This selection process was repeated on six occa-
sions until B8 was strongly cytoadherent (designated B8C'). Assays were performed using
sterile conditions, and incubation steps were carried out in the same gaseous environment
used for routine malaria culture (02, 5%; C02, 5%; N2, 90%). Parasites were maintained
in culture as previously described (29, 30).
Trypsin Sensitivity ofB8C' Cytoadherence.
￿
The trypsin sensitivity of B8C' cytoadherence to
C32 melanoma cells was compared with that of a K' ItG2F6 sibling clone, FAC8, using a
modification ofthe published method (31). Parasite cultures were washed three times in RPMI
1640 media (Gibco Laboratories, Grand Island, NY) buffered with Hepes (BDH Chemicals
Ltd., Poole, England). The cell pellets were resuspended in RPMI-Hepes containing trypsin
(Sigma Chemical Co., St. Louis, MO) at a final concentration of 10, 1, or 0.1 ug/ml. Soybean
trypsin inhibitor (100,ug/ml; Sigma Chemical Co.) was added simultaneously with trypsin
(10 pg/ml) to controls. Tubes were incubated at 37°C for 30 min, and trypsin inhibitor was
added to each tube to a final concentration of 10 times that of trypsin. 10% human serum
in RPMI-Hepes was added to each sample to achieve a finalvolume of 2 ml. Cytoadherence
assays were performed and results expressed as the number of infected erythrocytes bound
to 100 melanoma cells.
Cytoadherence to CD36and TSP .
￿
B8C' and a K' sibling clone, GBC6, were tested for cyto-
adherence to CD36 and TSP as described (15, 19). TSP was purified from platelets by affinity
chromatography on heparin Sepharose and shown to migrate as an Mr -180-kD protein by
SDS-PAGE (32). CD36 antigen was purified from Triton X-100detergent lysates ofplatelets
by affinity chromatography usingmAb IA7 coupled to Sepharose 4B. The column was washed
with 10 mM Tris,pH 7.6, 0.1% Triton X-100, and the protein was eluted with 10 mM diethyla-
mine, pH 12, 0.01% Triton X-100. The purified sample was analyzed by SDS-PAGE with
known standards, and silver stained. A single band ofM, -88 kD was evident. The concen-
tration of this protein was estimated by reference to the standards. The concentration and
purity of CD36 were confirmed by protein sequencing (Wilkinson, D., R. Aebersold, and
A. W. Boyd, unpublished results). To test for cytoadherence to CD36, tissue culture cover-BIGGS ET AL.
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slips (Thermanox; Miles Scientific, Naperville, IL) contained in the wells of a 24-well plate
(Linbro Chemical Co., Hamden, CT) were incubated with 10,1 of soluble CD36 (1 /~g/ml)
overnight at 4°C. This was followed by incubation with 1% BSA in PBS for 1 h at room
temperature. The coverslips were washed twice with RPMI-Hepes, and then 0.5 ml B8C'-
infected erythrocytes (2% hematocrit, 5-10% trophozoites) in 10% human serum in RPMI-
Hepes was added to each well. The plates were rocked gently at 37°C for 1 h, and unbound
erythrocytes were washed away with RPMI-Hepes. Bound erythrocytes were fixed in 2%
glutaraldehyde and stained with 10% giemsa. Cytoadherence to TSP was assayed similarly
except that TSP was diluted to 50 kg/ml in 1 mM CaC12, 10 mM Tris, 100 mM NaCl, pH
7.4. For blocking, BSA (1%) in 50 mM Tris, 5 mM CaC12, and 0.1 mM PMSF was used.
In both types ofassay, PBS and fibronectin (50 l~g/ml) were used as negative controls. Results
are expressed as the number of trophozoite-infected erythrocytes bound per mm2 .
Cytoadherence to Human Umbilical Vein Endothelial Cells (HUVEC).
￿
Cytoadherence assays were
performed as described previously (9). HUVEC were shown by immunofluorescence with
an anti-ICAM 1 mAb, WEHI-CAMI (33), and two anti-CD36 mAbs, IA7 and IE8, to ex-
press large amounts of ICAM 1, apparently on the cell surface, but little or no cell surface
CD36. mAbs IA7 and IE8 were raised against CD36 that had been affinity purified on Cl
Mega 1 antibody. Both IA7 and IE8 reacted with CD36 on the surface of platelets, mono-
cytes, and C32 melanoma cells. Results are expressed as the number ofinfected erythrocytes
bound to 100 endothelial cells. Two sibling K' ItG2F6 clones, FAF6 and GBC6, were in-
cluded in the same experiment as positive and negative controls.
Inhibition of Cytoadherence to Melanoma Cells and CD36.
￿
Melanoma cells or CD36-coated
coverslipswere preincubated for 1 h at 37°C with RPMI-Hepes containing either rabbit an-
tiserum to CD36, a mAb to CD36, FA6-152 (1/100 dilution of ascites; reference 34), soluble
TSP (50 l~g/ml), or a tetrapeptide known to be important in TSP-cell adhesion, asparagine,
glycine, aspartic acid, and serine (RGDS; 500 kg/ml). The mAb FA6-152, unlike IA7 and
1E8, had been previously shown to inhibit Cytoadherence of infected erythrocytes to mela-
noma cells (unpublished data). A rabbit antiserum was raised against purified platelet CD36.
This rabbit antiserum was shown to be specific for CD36 by immunoprecipitation ofa single
protein of M, -88 kD from 125I-labeled platelets and also by immunofluorescence analysis
of CD36* and CD36- cell lines. Preimmune rabbit serum was used as a control.
LabelingandImmunoprecipitation.
￿
Synchronized cultures (35) containing trophozoites were
used for surface radioiodination. The infected erythrocytes were purified to >99% parasitemia
by centrifugation through a Percoll gradient (36) before labeling. Alternatively, the cells were
incubated with a monolayer of C32 melanoma cells in 75-cm2 tissue culture flasks. Unin-
fected erythrocytes and nonadherent infected erythrocytes were removed by washing, and
the adherent infected erythrocytes were released from the melanoma cells by striking the
bottom of the flask briskly with the back of the hand. Purified infected erythrocytes were
surface radioiodinated using the lactoperoxidase technique (37). For metabolic labeling, cul-
tures were synchronized at the ring stage and cultured for 24 h with 35S methionine (100
p.Ci/ml; Amersham Corp., Arlington Heights, IL) until the parasites were trophozoites. The
infected erythrocytes were purified as described above.
Surface-labeled or metabolically labeled infected erythrocytes were incubated for 5 min
at 18°C with trypsin-L 1-tosylamide-2-phenylethylchloromethyl ketone (TPCK) (Worthington
Biochemical Corp., Freehold, NJ) at concentrations of 0.1, 1.0, or 10 wg/ml in PBS or with
trypsinTPCK (10 Fig/ml) and soybean trypsin inhibitor (100 hg/ml). An excess of soybean
trypsin inhibitor (100 l~g/ml) was added, the cells were washed with PBS, and then extracted
sequentially with I% (wt/wt) Triton X-100 followed by 2% (wt/wt) SDS, as previously de-
scribed (37).
Immunoprecipitation analysis was performed using pooled human sera collected from adults
residing in areas endemic for P . falciparum malaria and a mAb to the mature erythrocyte
surface antigen (MESA), mAb 8B7.4, that was kindly provided by Dr. Russell Howard, DNAX
Corp., Palo Alto, CA. The Triton X-100 and SDS extracts were diluted with equal volumes
of 10% Triton X-100 and 3 vol of 150 mM NaCl, 5 mM EDTA, 50 mM Tris, 0.5% (wt/vol)
Triton X-100, pH 7.4, and incubated with antibody for 18 h at 4°C. Immune complexes were
collected with protein A-Sepharose (Pharmacia Fine Chemicals, Piscataway, NJ), and the1886 KNOB-INDEPENDENT CYTOADHERENCE OF P . FALCIPARUM TO CD36
beads were washed asdescribed (38). Samples were boiled for 1 min and proteins separated
by electrophoresis in a 6% polyacrylamide gel. Labeledproteins wereidentifiedby autoradi-
ography.
Results
Cytoadherence to CD36 and TSP .
￿
The C32 melanoma cells used in these studies
were shown by immunofluorescence to express high levels ofCD36 and ICAM 1,
but very little TSP (data not shown). To determine which ofthese receptors were
important in the cytoadherence of B8C+, we performed experiments to test cytoad-
herence to purifiedTSP and CD36 immobilized on plastic coverslips, andto HUVEC
expressing ICAM 1 but little or no surface CD36. Soluble fibronectin was used as
a negative control. We found that B8C+ bound strongly to CD36 but showed min-
imal binding to TSP or fibronectin (Table I). The number of B8C+ trophozoite-
infected erythrocytes bindingto CD36 varied from 4,910 to 7,470 per mm2. Binding
of the K+ sibling clone, GBC6, varied from 5,200 to 14,170 infected erythrocytes
per mm2 in three different experiments. The binding ofB8C' to TSP was 20-50-
fold lower than that ofGBC6. In three different experiments, 90, 50, and 715 B8C+-
infected erythrocytes bound per mm2, compared with 1,965, 2,530, and 5,505
GBC6-infected erythrocytes per mm2.
Cytoadhrence to HUVEC Expressing ICAM 1.
￿
Both B8C+ and GBC6 failed to bind
to HUVEC (0, 2, and 3; and 10, 10, and 2 infected erythrocytes per 100 endothelial
cells in three different experiments) that were shown to express large amounts of
surface ICAM 1 (data not shown). Another K` sibling clone, FAF6, which was in-
cluded as a positive control, bound 276 infected erythrocytes per 100endothelialcells.
Inhibition of Cytoadherence to CD36 and Melanoma Cells by Antibody.
￿
The ability of
polyclonal and monoclonal antibodies raised against CD36 to block cytoadherence
was tested in order to determine if CD36 was the major receptor involved in the
cytoadherence of B8C' to C32 melanoma cells (see Table II). The cytoadherence
ofB8C' erythrocytes to CD36 was reduced 94% by the anti-CD36 mAb, FA6-152,
TABLE I
Cytoadherence of B8C' to CD36, TSP, and ICAM 1
` Results are presented as mean (range). Parasitemias were 5-10% trophozoites.
Results are expressed as the number ofinfected erythrocytes per 100 melanoma or endothelial
cells.
S Results are expressed as the number of infected erythrocytes bound per mm2.
II Immunofluorescence of HUVEC preparations confirmed the presence of endothelial cells
by positive staining for factor 8 . These cells were also shown to express large quantities of
ICAM 1 but very little CD36. A K' sibling clone, FAF6, bound 276 infected erythrocytes
per 100 endothelial cells, this serving as a positive control in this experiment.
Duplicate results from one experiment have been averaged.
Receptor B8C' (K- )' GBC6 (K')'
No. of
experiments
C32 melanoma ceelll 943 (488-1,606) 941 (775-1151) 3
TSP (50 lug/ml)S 285 (50-715) 3,333 (1,965-5,505) 3
CD36 (1 F+g/ml)S 6,571 (4,910-7,470) 8,503 (5,200-14,170) 3
HUVECIII 2 (0-3) 7 (2-10) 3
Fibronectin (50 tog/ml)S 135 135 1BIGGS ET AL.
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TABLE II
Inhibition of cytoadherence of B8C+ to CD36 and C32 Melanoma Cells
Preincubation with:
￿
CD36
￿
C32 melanoma cells
Preimmune rabbit sera'
1 :100 dilution
￿
4,0301
￿
8405
Rabbit antibody to CD36
1 :10 dilution
￿
ND
￿
96(89%)
Results from one representative experiment. Assays were performed in dupli-
cate and the mean result is shown.
' CD36 or C32 melanoma cells were preincubated with preimmune rabbit sera
or RPMI-Hepes as a positive control for each experiment.
t The results of cytoadherence to immobilized CD36 (1 ftg/ml) are expressed
as the number of infected erythrocytes bound per mm2.
5 The results ofcytoadherence to C32 melanoma cells are expressed as the number
of infected erythrocytes bound per 100 melanoma cells.
II Figures in parentheses represent the percentage inhibition of cytoadherence
when compared with the positive control for that experiment.
at adilution of 1:100, and 96% by a rabbit antiserum raised against purified CD36.
Similarly, cytoadherence to C32 melanoma cells was inhibited by FA6-152 (96%),
and the rabbit antiserum (88%) at dilution 1:100. Other experiments performed
using different dilutions of antibody gave comparable results (data not shown).
Effect ofRGDSand Soluble TSP on Cytoadherence.
￿
To determineifthe molecule respon-
sible forthe cytoadherence of B8C+ had a TSP-like moiety, we attempted to inhibit
cytoadherence to CD36 with the peptide RGDS, which is known to be important
in TSP-cell adhesion, and with soluble TSP (50 ftg/ml). Even at high concentration
(500 jug/ml), RGDS failed to inhibit cytoadherence of B8C+ to CD36 (Table II).
Soluble TSP inhibited cytoadherence of B8C+ to CD36 (67%) but did not inhibit
cytoadherence to C32 melanoma cells.
Trypsin Sensitivity of K- Cytoadherence.
￿
The trypsin sensitivity of proteins involved
in the cytoadherence of the K- cytoadherent clone B8C+ was compared with that
of a sibling K+ ItG2F6 clone. Binding of B8C+ was exquisitely sensitive to treat-
ment with trypsin at 0.1, 1.0, and 10 lug/ml, reducing cytoadherence by 56, 92, and
96%, respectively. This response was similar to the effect of trypsin on the K+ clone,
FAC8, for which cytoadherence was reduced by 31, 86, and 94%, respectively (see
Table III). Other experiments performed using different concentrations of trypsin
and different K+ ItG2F6 clones as controls gave similar results (data not shown).
1 :100 dilution
1 :1,000 dilution
RPMI-Hepes'
mAb FA6-152
140
ND
4,505
(967.)l 102 (88%)
419(50%)
ND
1 :10 dilution 0(100%) ND
1 :100 dilution 295 (94%) 33 (96%)
1 :1,000 dilution 1,435 (68%) ND
1 :10,000 dilution 4,470 ND
RPMI-Hepes' 5,746 740
Soluble TSP (50 kg/ml) 1,900 (67%) 752
RPMI-Hepes' 4,700 ND
RGDS peptide (0.5 mg/ml) 4,145 ND1888 KNOB-INDEPENDENT CYTOADHERENCE OF P . FALCIPARUM TO CD36
TABLE III
Trypsin Sensitivity ofB8C ` and a K' Sibling Clone, FAC8
Results from one representative experiment . Assays were performed in dupli-
cate and the mean result is shown .
' Results are expressed as the number of infected erythrocytes bound to 100
melanoma cells
1 The percent reduction in cytoadherence is shown in parentheses .
s Trypsin (10 Ag/ml) and trypsin inhibitor (100 Kg/ml) were added simultane-
ously to controls .
Surface Labeling ofInfected Cells .
￿
In previous studies, a surface radioiodinatable,
trypsin-sensitive, Triton X-100-insoluble protein (P . falciparum erythrocytemembrane
protein 1; PfEMP1) was identified on K'C+ -infected erythrocytes . By virtue of its
surface localization and trypsin sensitivity, NEMPI hasbeen implicated as apoten-
tial cytoadherence protein (31, 39) . To determine whether B8C'-infected erythro-
cytes expressed NEMP1, we surface radioiodinated infected erythrocytes containing
trophozoites . AnM r ^300-kD radioiodinated protein doublet was identified, which
like NEMPI, was cleaved by incubating the cells with trypsin (Fig. 1 A) . In contrast
to theNEMPI of K'C'-infected erythrocytes, the trypsin-sensitive radioiodinated
protein doublet on B8C' cells was present in both Triton X-100-soluble and -in-
FIGURE 1 .
￿
(A) Trypsin sensitivity and solubility
properties of radioiodinated proteins of B8C'-
infected erythrocytes. The intact radiciodinated
trophozoite-infected erythrocytes were incubated
with 10,ug/ml of trypsin (a) or with 10 F+g/ml of
trypsin plus 100 Wg/ml of soybean trypsin inhib-
itor (b). The cells were extracted with 1% Triton
X-100 (1), and the Triton X-100-insoluble residue
was extracted with 2olo SDS (2) . (B) Radioiodi-
nated proteins immunoprecipitated by pooled
human immune sera lane 1) or by anti-MESA
mAb 887.4 (lane 2); 5S methionine metaboli-
cally labeled proteins immunoprecipitated by
anti-MESA mAb 8137.4 (lane 3) . To the left of
the gel lanes are the molecular weight standards
(x 10-3 ) .
Trypsin
concentration B8C' ' FAC8
pg/ml %
10 35 (96)1 70 (94)
1 76 (92) 164 (86)
0 .1 392 (56) 825 (31)
Controls 900 1,192BIGGS ET AL.
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soluble fractions. It was immunoprecipitated by antibody from pooled human im-
mune sera (Fig. 1 B, lane 1), but not by the anti-MESA mAb 8137.4 (Fig. 1 B, lane
2). A high M, trypsin-sensitive protein was immunoprecipitated from K+ clones
GBC6 and FAF6, although this protein was not found in the Triton X-100-soluble
fraction (data not shown).
Discussion
The selection of a K- clone, B8C+, for strong cytoadherence to C32 melanoma
cells has enabled us to show that K--infected erythrocytes can bind to the leuko-
cyte differentiation antigen CD36. Cytoadherence to C32 melanoma cells was in-
hibited by both an anti-CD36 polyclonal rabbit antiserum and mAb FA6-152, sug-
gesting that CD36 is the major receptor involved in this type of cytoadherence.
Furthermore, B8C+ did not bind to HUVEC that were shown to express high levels
ofICAM 1 but little CD36 on the cell surface, suggesting that ICAM 1 is unlikely
to be an alternativereceptor forknob-independent cytoadherenceofthisclone. FAF6,
another P.falciparumclonederived from ITG2F6, did cytoadhere to endothelialcells,
but it has not been established whether this binding is via ICAM 1 or another en-
dothelial cell surface molecule.
In contrast to K+ clones, B8C+ showed very low levels ofadherence to TSP This
raises thepossibility that knobs or theexpression ofthe KAHRP may be important
in the cytoadherence of infected cells to TSP. It is also possible that the selection
ofB8C+ for cytoadherence to C32 melanoma cells, which are known to secrete only
small amounts of TSP (unpublished data), resulted in the selection of a parasite
expressing large amounts ofaprotein that specifically binds to CD36. Alternatively,
different domains in a single parasite molecule may mediate bindingto CD36 and
TSP If this is the case, the B8C+ cytoadherence molecule must have undergone a
modification that prevented cytoadherence to TSP Theobservation thatcytoadher-
ence of B8C+ to melanoma cells was abolished by the same low concentration of
trypsin (I lAg/ml) that is required to abolish cytoadherence of a number of other
lines favors the hypothesis that a single protein is involved in the cytoadherence of
both K+ and K- clones.
We identified a large radioiodinatable protein doublet on the surface ofB8C+-
infected erythrocytes . Like the putative cytoadherence molecule PfEMPI (31, 37),
these proteins were cleaved by incubating infected erythrocytes with the same low
concentration oftrypsin that abolishes cytoadherence. Unlike PfEMPI, however, the
proteins were partially soluble in 17o Triton X-100. These radioiodinated proteins
were shown todiffer from MESAby immunoprecipitation analysis with mAb 8B7.4.
This anti-MESA mAb immunoprecipitated an Mr -300-kD metabolically labeled
protein, but not the trypsin-sensitive, radioiodinated protein doublet. We suggest
that the M, -300-kD radioiodinated protein doublet ofW'-infected erythrocytes
isPfEMP1, and that its solubility with Triton X-100 is due todifferences inthe inter-
action ofthe proteins with the erythrocyte membrane and membrane skeleton in
K-C+ cells compared with K+C+ cells. PfEMPI has not been detected previously
in K- lines (36). Our observation ofa PfEMPI-like molecule associated with K-C+-
infectederythrocytes isconsistentwith arolefor PfEMPI in cytoadherence to CD36
and C32 melanoma cells, and indicates that the expression ofPfEMPI on the sur-
face, andcytoadherenceto CD36, can occurindependentlyofthe presence ofknobs.1890 KNOB-INDEPENDENT CYTOADHERENCE OF P. FALCIPARUM TO CD36
Although cytoadherence of the asexual stages of P, falciparum to CD36 may occur
in the absence ofknobs, this may not be relevant to malaria in vivo. Previous reports
suggest a good correlation between the presence of knobs, sequestration, and viru-
lence in vivo (5, 40). It is conceivable that the expression of KAHRP and/or knobs
on the erythrocyte surface allows initial low affinity attachment to TSP present at
the endothelial cell surface. High affinity attachment may then occur via CD36 and
perhaps other host cell receptors, such as ICAM 1. The knob-independent mecha-
nism ofcytoadherence to CD36 may be ofprimary importance in the cytoadherence
to endothelial cells of other malaria species and of the immature sexual stages of
P. falciparum.
Summary
The survival of Plasmodium falciparum-infected erythrocytes is enhanced by the
sequestration of mature trophozoites and schizonts from the peripheral circulation.
Cytoadherence of infected erythrocytes in vivo is associated with the presence of
knobs on the erythrocyte surface (40), but we and others have shown recently that
cytoadherence to C32 melanoma cells may occur in vitro in the absence of knobs
(26, 27). We show here that a knobless clone ofP. falciparumadheres to the leukocyte
differentiation antigen, CD36, suggesting that binding to CD36 is independent of
the presence of knobs on the surface ofthe infected erythrocyte. This clone showed
little cytoadherence to immobilized thrombospondin or to endothelial cellsexpressing
the intercellular adhesion molecule l. Furthermore, an Mr -300-kD trypsin-sen-
sitive protein doublet was immunoprecipitated from knobless trophozoite-infected
erythrocytes. Finding a P. falciparum erythrocyte membrane protein 1 (PfEMP1)-
like molecule on these infected erythrocytes is consistent with a role for PfEMPI
in cytoadherence to CD36 and C32 melanoma cells.
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